Critical Reviews in Biotechnology (CRB) is a scholarly journal dedicated to publishing research in the field of Medicine. Taylor and Francis is the publisher of this esteemed journal. The P-ISSN assigned to Critical Reviews in Biotechnology is 0738-8551 and its abbreviated form is Crit Rev Biotechnol.
Biotechnological techniques, from fermentation to genetic manipulation, have become increasingly relevant to the food and beverage, fuel production, chemical and pharmaceutical, and waste management industries. Consequently, academic as well as industrial institutions need to keep abreast of the concepts, data, and methodologies evolved by continuing research. This journal provides a forum of critical evaluation of recent and current publications and, periodically, for state-of-the-art reports from various geographic areas around the world. Contributing authors are recognized experts in their fields, and each article is reviewed by an objective expert to ensure accuracy and objectivity of the presentation.
Journal title | Critical Reviews in Biotechnology (CRB) |
Abbreviation | Crit Rev Biotechnol |
Print ISSN | 0738-8551 |
Online ISSN | 1549-7801 |
Publisher Name | Taylor and Francis |
Editor-in-chief | Graham G. Stewart - GGS Associates, Rhiwbina, Cardiff, Wales, UK |
Subject Category | Medicine |
Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Critical Reviews in Biotechnology Journal is Crit Rev Biotechnol.
The Ranking of the Journal in 2024 is 1836. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Journal's Impact Factor in 2024 is 9.5. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The Journal SCImago in 2024 is 1.637. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The Acceptance Rate in 2024 is 33%. It is a measure that provides insight into the selectivity and competitiveness of a journal's editorial process.
The Journal's H-Index in 2024 is 113. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The Journal is indexed in (Indexing details)
PubMed | Scopus | Web of Science | UGC | Embase | DOAJ |
---|---|---|---|---|---|
✅ | ✅ | ✅ | ✅ | ❌ | ❌ |
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
Abbreviation | Crit Rev Biotechnol |
Access type | Hybrid |
Acceptance rate | 33% |
Impact Factor | 9.5 |
SJR | 1.637 |
SNIP | 2.271 |
Ranking | 1836 |
CiteScore | 17.5 |
H-Index | 113 |
The Editor-in-chief of the Journal is Graham G. Stewart - GGS Associates, Rhiwbina, Cardiff, Wales, UK
Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of the Journal is 2750 GBP
Call for paper : The Journal invites original research contributions for consideration of publication in Critical Reviews in Biotechnology journal.
Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in Critical Reviews in Biotechnology involves the following steps:
Yes, the journal is indexed in PubMed.
Yes, the journal is indexed in Scopus.
Yes, the journal is indexed in UGC.
No, the journal is not indexed in Index copernicus.
No, journal is not a predatory journal.
The Impact Factor of the Journal is 9.5.
The Ranking of the Journal is 1836.
Yes the journal is a peer-reviewed journal.
Yes the journal is a peer-reviewed journal and good to publish your paper.
Critical Reviews in Biotechnology (CRB) is a scholarly journal dedicated to publishing research in the field of Medicine. Taylor and Francis is the publisher of this esteemed journal.
Yes, Critical Reviews in Biotechnology is a open access (Hybrid) journal.